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The glucocorticoid receptor (GR), like many signaling
proteins, depends on the Hsp90 molecular chap-
erone for in vivo function. Although Hsp90 is required
for ligand binding in vivo, purified apo GR is capable
of binding ligand with no enhancement from Hsp90.
We reveal that Hsp70, known to facilitate client deliv-
ery to Hsp90, inactivates GR through partial unfold-
ing, whereas Hsp90 reverses this inactivation. Full
recovery of ligand binding requires ATP hydrolysis
on Hsp90 and the Hop and p23 cochaperones. Sur-
prisingly, Hsp90 ATP hydrolysis appears to regulate
client transfer from Hsp70, likely through a coupling
of the two chaperone’s ATP cycles. Such coupling
is embodied in contacts between Hsp90 and Hsp70
in the GR:Hsp70:Hsp90:Hop complex imaged by cry-
oelectron microscopy. Whereas GR released from
Hsp70 is aggregation prone, release fromHsp90 pro-
tects GR from aggregation and enhances its ligand
affinity. Together, this illustrates how coordinated
chaperone interactions can enhance stability, func-
tion, and regulation.
INTRODUCTION
Heat shock protein 90 (Hsp90) is a ubiquitous ATP-dependent
molecular chaperone required for activation of numerous client
proteins, many involved in the progression of cancer and other
diseases (Taipale et al., 2010). Whereas most canonical chaper-
ones, such as Hsp70, recognize unfolded proteins, Hsp90 is
unique because it acts in the later stages of folding by binding
to partially folded intermediates (Jakob et al., 1995). Extensive
studies have revealed a complex ATP hydrolysis cycle in which
Hsp90 undergoes dramatic conformational rearrangements
(Krukenberg et al., 2011). Hsp90 is a high-affinity homodimer
that is dimerized in the apo state through its C-terminal domain
(CTD) and adopts an extended V-shaped conformation (Kruken-
berg et al., 2008). The N-terminal domains (NTDs) contain thenucleotide binding sites, and ATP binding stabilizes domain rear-
rangements such that the arms come together in an NTD-dimer-
ized closed conformation (Ali et al., 2006), which promotes ATP
hydrolysis (Wegele et al., 2003). Although Hsp90’s ATP hydroly-
sis (ATPase) activity is essential (Obermann et al., 1998), it is un-
clear how ATP hydrolysis promotes client folding and activation.
The glucocorticoid receptor (GR), a ligand-activated transcrip-
tion factor involved in critical biological processes (Chrousos
and Kino, 2009), is a well-known obligate Hsp90 client. In vivo
Hsp90 is required for GR to bind ligand and become active (Pic-
ard et al., 1990). To varying degrees, Hsp90 interacts with other
steroid hormone nuclear receptors such as the progesterone
receptor (PR). Like most nuclear receptors, GR’s activity is regu-
lated through its C-terminal ligand binding domain (LBD), a
mostly helical structure with the ligand binding pocket located
in the core of the domain. In the absence of ligand, LBDs are
thought to be dynamic, with the ligand providing both structural
stability and allosteric control of the LBD’s ability to interact with
coregulator proteins to modulate transcription (Bain et al., 2007).
Hsp90 interacts directly with GR through its LBD (GRLBD)
(Howard et al., 1990).
It is unclear why Hsp90 is required or how Hsp90 activates
GR for ligand binding. Early reconstitution experiments with
GR (Pratt et al., 2006) and with PR established that the central
proteins in the maturation pathway include Hsp40, Hsp70,
Hsp90, Hsp70/Hsp90Organizing Protein (Hop), and p23 (Dittmar
et al., 1996; Kosano et al., 1998). These experiments defined a
general order in which proteins enter and exit the pathway (Mor-
ishima et al., 2000b), with Hsp40 and Hsp70 acting first to deliver
the receptor to Hsp90 (Herna´ndez et al., 2002; Smith et al.,
1992). Hop was originally thought to act solely as an adaptor
protein that facilitates delivery by providing a physical link be-
tween the two chaperones (Chen and Smith, 1998). However,
a recent cryoelectron microscopy (cryo-EM) reconstruction of
the Hsp90:Hop complex reveals that Hop forms extensive inter-
actions with Hsp90, preorganizing Hsp90 NTDs for ATP hydroly-
sis and client binding (Southworth and Agard, 2011). The second
Hsp90 co-chaperone, p23, acts later in the pathway, binding to
the Hsp90 complex in which GR is in its ligand binding compe-
tent state (Dittmar et al., 1997). Although Hop and p23 bind
to distinct regions on Hsp90, their binding is competitive. HopCell 157, 1685–1697, June 19, 2014 ª2014 Elsevier Inc. 1685
Figure 1. GR Ligand Binding Activity In Vitro
Is Hsp90 Independent
(A) Equilibrium binding of 20 nM F-dex to GRLBD
measured by fluorescence polarization (±SD).
Binding curve fit a KD of 154 ± 14 nM (±SEM).
(B) Equilibrium binding with 5 mM ATP/MgCl2.
GRLBD alone (blue) and with 5 mM Hsp90 (red)
(±SD) are shown.binds to the open state, whereas p23 requires the closed nucle-
otide-bound state (Figure 4A).
Like most obligate Hsp90 clients, in-depth biochemical investi-
gation of GR has been hindered by difficulty obtaining stable apo
protein for in vitro investigation. As a result, previous GR studies
have been carried out with proteins of variable quality and limited
to basic characterizations. That said, in one of the first purely
in vitro investigations, denatured and refolded GRLBD was re-
ported to stimulateHsp90’s hydrolysis, indicating a direct interac-
tionbetweenpurifiedHsp90andGRLBD (McLaughlinet al., 2002).
The aim of our investigation was to determine in detail how
Hsp90 promotes GR ligand binding and, in so doing, provide
much needed insight into howHsp90 activates a bona fide client.
Using highly purified recombinant proteins in an entirely in vitro
system, we directly measure GRLBD ligand binding. Contrary to
in vivo, our purified apo GRLBD binds ligand without aid or
enhancement from Hsp90. Working under conditions where apo
GR is stable, the biological dependence on Hsp90 could only be
fully understood in the context of the entire chaperone system
that includes Hsp70, Hsp90, and three specific cochaperones.
Under these conditions, we find that the Hsp70 and Hsp90 chap-
erone cycles are intimately connected, with Hsp70 and Hsp90
working collaboratively to regulate and enhance GR function.
RESULTS
Purified GRLBD Binds Ligand without Hsp90
To obtain workable quantities of GRLBD, while keeping as close
as possible to wild-type (WT), we utilized a single solubility
enhancing mutation (F602S) (Ricketson et al., 2007). Although
less dependent on Hsp90 for activation in vivo, this mutation al-
lows for large-scale expression in bacteria (Bledsoe et al., 2002).
GRLBD(F602S), referred to as GRLBD unless otherwise speci-
fied, was purified to homogeneity in the presence of ligand fol-
lowed by extensive dialysis to remove the ligand. The GRLBD
could be purified and obtained in the apo state without a solubi-
lity tag; however, an N-terminal maltose binding protein (MBP)
tag was verified to not interfere with the shown experiments
and was generally retained because it enhanced stability over
long experimental time courses.
Ligand binding was monitored by measuring the increase of
fluorescence polarization of fluorescein-labeled dexamethasone1686 Cell 157, 1685–1697, June 19, 2014 ª2014 Elsevier Inc.(F-dex) as it bound to GRLBD. As previ-
ously reported, but in contrast to in vivo
(Bledsoe et al., 2002), purified GRLBD
can bind ligand in the absence of chaper-
ones (Figure 1). The kinetics of F-dex
binding displayed standard single-phaseassociation and dissociation kinetics, with association taking
place much faster than dissociation, indicating that our GRLBD
is ligand-free. Under our experimental conditions, equilibrium
measurements result in a dissociation constant (KD) of 150 ±
20 nM (Figure 1A). Given the dramatic effect of Hsp90 in vivo,
we were surprised that no enhancement in ligand binding by
Hsp90 was detected (Figure 1B). Even with p23 and Hop, no sig-
nificant Hsp90 effect was observed (data not shown). In addition,
we were unable to reproduce the previously reported stimulation
of Hsp90’s ATPase activity by GRLBD, although we noted that
the detergent used previously to stabilize GRLBD could also
stimulate ATPase activity. In contrast, working with the yeast
Hsp90 for which a more robust ATPase rate is observed, we
confirmed the recently reported inhibition by GRLBD (Lorenz
et al., 2014) (data not shown).
Because mutations in GRLBD are known to influence
GRLBD’s conformation and ligand binding properties (Pfaff
and Fletterick, 2010; Ricketson et al., 2007), we wanted to
ensure that the F602Smutation was not responsible for the inde-
pendently functional GRLBD or lack of ATPase acceleration.
From the small amount of WT GRLBD that could be purified,
WT GRLBD was not only capable of binding ligand but had a
higher affinity than the F602S mutant (Figure S1A available on-
line), a trend consistent with a previous report by Ricketson
et al. (2007). Using WT GRLBD, we were still unable to detect a
significant effect on Hsp90’s ATPase rate (data not shown).
Notably, our purified GRLBD is in a very different functional state
than the denatured and refolded protein for which ATPase stim-
ulation was observed. In addition to the nearly 300-fold differ-
ence in ligand affinities (150 nM compared to 46 mM), both our
purified apo F602S andWTGRLBD aremonomeric (Figure S2B),
whereas the refolded protein was dimeric (McLaughlin and Jack-
son, 2002), suggesting that these two studies should not be
compared. In summary, independent of the F602S mutation,
our purified GRLBD can function on its own, and we were unable
to detect any significant high-affinity functional interaction
between just GRLBD and Hsp90.
Hsp70 Inhibits GR Ligand Binding by Partially
Unfolding GR
Because Hsp70 can facilitate client delivery to Hsp90, we
reasoned that Hsp70 might stabilize a state of GRLBD better
Figure 2. Hsp70 Inhibits GR Ligand Binding
(A) Association kinetics of F-dex to GRLBD (blue),
with Hsp40 (yellow), with Hsp70 and ATP (black),
and with Hsp40, Hsp70, and ATP (red). Assay
conditions were 5 mM ATP/MgCl2, 50 nM F-dex,
1 mM MBP-GRLBD, 2 mM Hsp40, and 15 mM
Hsp70.
(B) Chaperone cycle of Hsp70. ATP-bound NBD
opens the SBD such that substrate binding
is weak. Substrate and Hsp40 stimulate ATP hy-
drolysis, resulting in a high-affinity substrate-
bound state with the lid latched down. Substrate
release occurs upon ADP:ATP exchange pro-
moted by NEFs.
(C) Hsp70 concentration dependence of equilib-
rium binding of 1 mMMBP-GRLBD to 20 nM F-dex
(with 2 mM Hsp40) (±SD). Fitting a cooperative
competitive binding model yields an IC50 of 4.6 ±
0.4 mM and a Hill coefficient of 1.6 ± 0.4 mM
(±SEM).
(D) Dissociation of 100 nM F-dex from MBP-
GRLBD (with 2 mM Hsp40) initiated with excess
(100 mM) unlabeled dex (blue), and with 15 mM
Hsp70 (red), fit to a single exponential decay.
Inset shows average off rate: 0.029 ± 0.002 min1
and 0.066 ± 0.005 min1 with Hsp70 (±SEM).
See also Figure S1.capable of interactingwithHsp90, therefore enhancing any effect
Hsp90 might have on ligand binding. Remarkably, apo GRLBD
preincubated with just the Hsp70 system resulted in complete
inhibitionofGRLBD ligandbinding (Figure 2A).Basedonprevious
studies by Dittmar et al. (1998), we used substoichiometric
amounts of yeast Hsp40 (Ydj1) to accelerate Hsp70 ATP hydroly-
sis.With ATP, theHsp70 substrate binding lid is open, and hydro-
lysis triggers allosteric changes that lead to closure of the lid,
promoting stable high-affinity substrate binding and protection
from aggregation (Figure 2B) (Mayer and Bukau, 2005). Hsp40
has no effect on its own but is required for GRLBD inhibition
(Figure 2A) and to promote stable binding of Hsp70 to GRLBD
(Figure S1D). ATP hydrolysis is also essential because noGRLBD
inhibition is observed with ADP or the nonhydrolyzable ATP
analog, adenylyl-imidodiphosphate (AMPPNP) (Figure S1C).
The concentration dependence of Hsp70 shows a cooperative
mode of inhibition with a half-maximal inhibitory concentration
(IC50) of 4.6 ± 0.6 mMand aHill coefficient of 1.6 ± 0.6 (Figure 2C).
The F602S mutation had no effect on the IC50 (Figure S1E).
Although these data show that Hsp70 can bind to apo GRLBD
and prevent ligand binding, we wanted to know if Hsp70 actively
displaces ligand from an already ligand-bound GRLBD. To
investigate this, GRLBD was pre-equilibrated with Hsp40 and
F-dex and ligand dissociation initiated by excess unlabeled
dex with and without Hsp70 (Figure 2D). We found that Hsp70
accelerated F-dex dissociation more than 2-fold, revealing that
Hsp70 can directly catalyze ligand removal from GRLBD.Cell 157, 1685–169From the above, we hypothesized that
Hsp70 is actively promoting GRLBD un-
folding, thereby disrupting the conforma-
tion required for ligand recognition. Ourexpectation was that Hsp70 would significantly shift the equilib-
rium toward a completely unfolded GRLBD. However, limited
proteolysis showed an increased sensitivity in only a single re-
gion (helix 3, Figure S2A). Hsp70-induced unfolding was more
quantitatively investigated by hydrogen deuterium exchange
coupled with mass spectrometry (HDX-MS). Although Hsp40
alone had no effect (data not shown), with both Hsp70 and
Hsp40, there was a significant increase in HDX in three limited
GRLBD regions (Figures 3 and S2). The most extensive increase
was on helix 3 (residues 564–573) and then the b sheet region
(residues 621–631). This correlates with the limited proteolysis,
confirming that Hsp70 induces only local unfolding. Interestingly,
in addition to disrupting local structure and important hydropho-
bic contacts with the ligand, the region on helix 3 that was most
affected contains residues N564 and Q570, which form three of
the six hydrogen bonds between GRLBD and the ligand (Fig-
ure 3). This indicates that whereas the degree of overall unfolding
is minimal, it is located for optimal disruption of ligand binding.
Hsp90 Recovers GR Ligand Binding
Given that Hsp90 is essential in vivo for ligand binding, and
our finding that Hsp70 holds GRLBD in an inactive state, we
explored Hsp90’s ability to liberate GRLBD from Hsp70 inhibi-
tion. Including Hsp90 in the preincubation with Hsp70 and
Hsp40 resulted in minimal recovery of ligand binding (Figures
4B and 4C). By contrast, significant recovery occurred with
Hsp90 and either Hop or p23. Full recovery required both7, June 19, 2014 ª2014 Elsevier Inc. 1687
Figure 3. HDX-MS Detects Partial Unfolding of GRLBD by Hsp70
Differential HDX betweenGRLBD andHsp70-boundGRLBDmapped onto the dex-bound crystal structure of GRLBD (1M2Z). Differences in the average HDX are
represented as percent change and colored according to the key with orange being faster with Hsp70. Number within parentheses is the SD among three
replicates. Corresponding deuterium buildup curves for the regions that undergo the most significant conformational change are shown (±SD). Top right shows
zoom in on dex, and the three hydrogen bonds formed with helix 3. See also Figure S2.cochaperones. The concentrations used for Hop and p23 were
saturating in their effect; thus, partial recovery was not due to
insufficient protein (data not shown). Ligand binding recovery
was entirely dependent on Hsp90 because no recovery
was seen without Hsp90 or with the specific Hsp90 inhibitor,
17AAG. Thus, Hsp90 is the active component required for re-
covery of ligand binding, recapitulating its in vivo requirement.
Interestingly, the Hsp90 concentration dependence of GRLBD
recovery saturates at stoichiometric amounts of Hsp90 dimer
and GRLBD (Figure 4D). This suggests a 1:1 interaction between
monomeric GRLBD and dimeric Hsp90 and indicates tight bind-
ing of Hsp90 and cochaperones to the Hsp70:GRLBD complex,
with an estimated KD on the order of 200 nM or less.
Release of Hsp70 Inhibition Requires ATP Hydrolysis by
Hsp90
Inhibition by 17AAG, which binds to Hsp90’s ATP binding pocket
and prevents nucleotide binding, indicates the importance of
ATP for recovery of GRLBD ligand binding. To explore further,
we utilized two previously characterized hydrolysis-dead
mutations in Hsp90: D93N, which cannot bind nucleotide, and
E47A, which can bind nucleotide and close but cannot hydrolyze
ATP (Obermann et al., 1998). Neither mutant was able to recover
ligand binding (Figure 4D), indicating that both nucleotide bind-
ing and hydrolysis are required to reverse Hsp70 inhibition.
Pull-down studies show that in the presence of the chaper-
ones, an Hsp90:Hsp70:Hop:GRLBD complex forms and that
neither 17AAG nor the Hsp90 mutations prevent formation of1688 Cell 157, 1685–1697, June 19, 2014 ª2014 Elsevier Inc.this large complex (Figure S3). By contrast, inhibition of ATP
hydrolysis caused a loss in p23 association. Binding of p23
and Hop appears weaker than the other components and was
additionally probed by western blot. This confirmed the pres-
ence of Hop and revealed no detectable incorporation of p23
with either Hsp90 mutant or 17AAG (Figure S3). For D93N, this
is expected because this mutant cannot bind ATP, which is
required to stabilize the closed state to which p23 binds (Ali
et al., 2006). By contrast, the significant loss in p23 binding to
the GR complex with the E47Amutant was unexpected because
E47A has been shown to support the binary interaction between
p23 and Hsp90 (Johnson et al., 2007). The loss of p23 binding
to the E47A mutant in the context of the full system indicates
that p23 association is inhibited by some component of the
Hsp90:GR complex prior to hydrolysis.
This, in combination with the inability to restore ligand binding,
clearly illustrates that hydrolysis on Hsp90 facilitates an essential
step in the pathway required for the release of Hsp70’s inhibition
and that blocking hydrolysis results in a stalled inactive inter-
mediate complex with Hsp70, Hsp90, and Hop, but not p23.
Consequently, p23’s role in the receptor maturation pathway
must occur on a posthydrolysis state of Hsp90.
The Coordinated Action of Hsp70 and Hsp90 Enhances
GR Ligand Affinity
When investigating ligand binding recovery in response to
the full chaperone system, we noticed a slight enhancement
in the amount of GRLBD bound to ligand (Figure 4C). This
enhancement is not due to activating a previously inactive
portion of the GRLBD population because the entire chaperone
system did not change the specific activity of GRLBD (Fig-
ure S4A). Instead, the full chaperone system accelerates the
ligand association rate in an Hsp90 concentration-dependent
manner (Figure S4B). Comparing the association and dissocia-
tion rates of F-dex to GRLBD alone or GRLBD pre-equilibrated
with saturating amounts of the entire chaperone system (Fig-
ure 4B) revealed acceleration in both the association (Figure 4E)
and dissociation rates (Figure 4F). The dissociation rate seen
was about 1.5-fold faster, similar to that measured with just
the Hsp70 system (Figure 2C). On rates were determined from
the slope of the linear fit of the kobs measured at different GRLBD
concentrations (Figure 4G), revealing 2-fold faster on rate with
chaperones (Figure S4C). Additionally, equilibrium measure-
ments show3-fold enhancement in the KDwith the chaperones
(Figures 4H, 4I, and S4E). These data indicate that within the full
chaperone system, Hsp90 holds GRLBD in a higher ligand affin-
ity conformation than GRLBD alone and, thus, suggest that the
chaperone-bound complex is directly capable of binding ligand.
Cryo-EM Map of Hsp90:Hop:Hsp70:GR Complex
Supports Coupling of Hsp90 and Hsp70 ATP Hydrolysis
Cycles
To provide a structural framework for understanding the hand
off of GR between Hsp70 and Hsp90, we purified the intermedi-
ate complex having one Hsp90 dimer and one copy each of
Hsp70, Hop, and GRLBD (Figure S5) and utilized single-particle
cryo-EM to obtain a 3D reconstruction. The assembly reactions
and running buffers were used with the intention of capturing the
GRLBD-bound ADP state of Hsp70 and the apo Hop-bound
state of Hsp90. Although resolution of the reconstruction is esti-
mated to be 38 A˚ and likely limited by sample heterogeneity, the
size and distinct shape of the individual Hsp90 and Hsp70 do-
mains allowed the general organization of these components in
the complex to be determined with high confidence (Figure 5).
Hsp90 is in a V-shaped state similar to the previous Hsp90-
Hop electron microscopy (EM) structure (Southworth and Agard,
2011); however, the overall Hsp90 organization is distinctly
asymmetric with only one monomer having the fully rotated
NTD orientation seen in the Hop complex and in the Hsp90
closed ATP state crystal structure (Ali et al., 2006). To fit our den-
sity, the other Hsp90 NTD needs to be rotated 23 outward
about the NTD-middle domain (MD) interface (Figure S6A). The
opposing Hsp90 monomer that fits the Hop-induced conforma-
tion has two regions of extra density centered on the MD,
which likely corresponds toHop domains shown to be necessary
and sufficient for GR activation (tetratricopeptide repeat 2A
[TPR2A], TPR2B, and DP2) (Schmid et al., 2012).
The most distinguishable feature of the complex is the Hsp70
substrate binding domain (SBD), which has extra density from
the substrate binding site on Hsp70 extending to the MD and
CTD interface of Hsp90, suggesting that GRLBD is simulta-
neously bound to both Hsp90 and Hsp70. Additionally, Hsp70
appears to be delivering GRLBD directly to the client binding
site originally identified on the E. coli Hsp90 (Genest et al.,
2013). When tested in yeast, mutations in this region had a
significant impact on GR signaling in vivo. Indeed, the portionof the binding site mapped to the CTD amphipathic helix had
been suggested to make direct contact with apo GRLBD (Fang
et al., 2006).
As expected for Hsp70 in the ADP state, the Hsp70 SBD is
separated from its nucleotide binding domain (NBD). Not only
is there a distinct orientation between the two domains, but con-
necting density is also visible (Figure 5C). A surprising aspect of
the reconstruction is that the Hsp70 NBD is nestled between the
two Hsp90 NTDs. A direct contact between Hsp90 and Hsp70
was unexpected because in vitro binding between Hsp90 and
Hsp70 is only detected in the presence of Hop, which binds
both independently through separate TPR domains. This led
to the conclusion that Hop was a passive linker and that the
Hsp70:Hsp90 interaction was purely through the physical
connection to Hop. Although the Hsp70 NBD seems to contact
both Hsp90 NTDs, it makes a stronger connection with the
ATPase domain of the Hop-bound Hsp90 monomer. Formation
of this connection requires the Hsp90 conformation induced by
Hop, indicating that not only does Hop preorganize Hsp90 for
receiving clients but also for interaction with Hsp70.
Utilizing the Hsp70 domain linker as a restraint, Hsp70 NTD
best fits into the EM density such that the IB lobe is in proximity
to the Hop arm of Hsp90, and the base of the IIA lobe is in prox-
imity to the opposing Hsp90 NTD (Figure 5D). Intriguingly, this
orientation suggests that the lid of the Hsp90 nucleotide binding
pocket is in the region making contacts with Hsp70 NBD. The
functional implications of this potential interaction are significant
because the direct contact between the ATPase domains of
Hsp70 and Hsp90 provides a structural basis for the coupling
of the two hydrolysis cycles suggested by our ligand binding
studies.
Hsp90 Is an Hsp70 Release Factor with Chaperone
Function
The experiments above suggest a model in which Hsp90 re-
verses the Hsp70 inhibition in a process that requires ATP hydro-
lysis by Hsp90, likely by promoting Hsp70 release from GRLBD.
In the absence of other factors, substrate release from Hsp70 is
slow but is facilitated by nucleotide exchange factors (NEFs) that
accelerate ADP release, allowing ATP rebinding, and opening of
the substrate binding site and lid (Mayer and Bukau, 2005). We
sought to directly contrast Hsp90 with a traditional Hsp70
exchange factor in the GR ligand binding assay. We chose the
well-characterized Bag-1 due to its ability to stimulate Hsp70
ADP and client release (Sondermann et al., 2001), and evidence
that Bag-1 acts in the GR degradation pathway (Demand et al.,
2001).
Bag-1-induced GRLBD release from Hsp70 was confirmed
by pull-down (Figure S1D). For functional comparison, we pre-
formed the inhibited Hsp70-GRLBD complex and then moni-
tored the kinetics of F-dex binding resulting from Hsp70 release
stimulated by either Bag-1, or Hsp90 plus Hop and p23 (Fig-
ure 6A). Under these conditions, the Hsp90 system showed a
lag phase for ligand binding recovery (Figures 6B and S7A).
The slow recovery can be explained as the time required for
the Hsp70-Hsp90 client handoff given its dependence on the
slow Hsp90 hydrolysis rate. Indeed, previous results indicated
that Hsp90 ATP hydrolysis is the rate-limiting step in the cycleCell 157, 1685–1697, June 19, 2014 ª2014 Elsevier Inc. 1689
Figure 4. Hsp90 System Recovers GR Ligand Binding from Hsp70 Inhibition and Enhances Ligand Association
(A) Without nucleotide, Hsp90 is in an extended open state. Rotation of the NTD about the MD interface is required for dimerization of the NTDs in the ATP-
stabilized closed state. Hop binds the intermediate open state with rotated NTDs, and p23 binds the closed ATP-bound state.
(legend continued on next page)
1690 Cell 157, 1685–1697, June 19, 2014 ª2014 Elsevier Inc.
(Morishima et al., 2001). With Hsp90, full ligand binding is
restored by 40 min and maintained for the duration of the exper-
iment. Bag-1 functioned very quickly with a fast recovery of
ligand binding (<10 min). The ligand association rate observed
by release with Bag-1 is2-fold faster than the basal association
of F-dex to GRLBD on its own; however, this is followed by a
steady decrease in ligand binding. This decrease is relatively
slow and occurs linearly with time until almost all ligand binding
is lost by 3 hr. Increase in light scattering demonstrated that the
loss of function correlates with aggregation (Figure 6C). It should
be noted that GRLBD alone, without chaperones, was able to
maintain full ligand binding during the course of the experiment
and shows no aggregation at this temperature by light scattering.
This shows that GRLBD directly released from Hsp70, but not
from the Hsp90 system, is in an aggregation prone state,
implying that an additional GRLBD folding likely occurs on
Hsp90. This indicates two distinct functions of Hsp90: one being
the release of GRLBD from Hsp70, and the other being a chap-
erone function.
Although Hsp90’s ability to reverse the Hsp70 inhibition is
dependent on ATP hydrolysis (Figure 4B), we wanted to deter-
mine if the chaperone function is as well. To this end, we inves-
tigated the combined effects of Bag-1 and Hsp90 (with Hop and
p23). When added together, a fast Bag-1-like recovery is seen,
but then the full activity is maintained by the Hsp90 system (Fig-
ure 6B). This indicates that in the context of Hsp70 release by
Bag-1, Hsp90 with Hop and p23 can function to prevent GRLBD
loss of function. To truly decouple the Hsp70 release from the
chaperone function, Bag-1 was added with hydrolysis-dead
Hsp90 E47A (with Hop and p23). With Bag-1, the Hsp90 E47A
is just as capable as the WT Hsp90 at preventing GRLBD loss
of function (Figure 6B), clearly showing that the chaperone func-
tion is independent of ATP hydrolysis. This correlates with early
work that showed that Hsp90’s ability to interact with unfolded
intermediates and prevent aggregation is ATP independent
(Jakob et al., 1995).
Further investigation into the combined effect with Bag-1 and
Hsp90 revealed that the absence of Hop and p23 resulted in only
partial suppression of the loss of function, indicating that both
cochaperones are required to fully maintain GRLBD function
(Figure S7B). Equivalent loss of function was seen without p23(B) Experimental scheme.
(C) Equilibrium binding of 20 nMF-dex to 1 mMMBP-GRLBDwith different chaper
15 mM Hsp70, Hsp90, Hop, and p23.
(D) Saturation plot for binding of 20 nM F-dex to 1 mM MBP-GRLBD with 2 mM H
hydrolysis-dead Hsp90; E47A is shown in black and D93N in blue (±SD). WT Hsp9
(E) Association kinetics of 20 nM F-dex to 300 nM MBP-GRLBD alone (blue) and
phase association.
(F) Normalized dissociation kinetics of 100 nM F-dex bound to 1 mMMBP-GRLB
(red). Off rates are respectively 0.041 ± 0.004 min1 and 0.059 ± 0.002 min1 (±S
(G) Average kobs versus GRLBD concentration from three to five separate experim
Hop, and p23 (red) (±SEM). On rates determined from the slope of the linear fit to
(± weighted error of slope) are shown (Figure S4C).
(H) Normalized equilibrium binding of 20 nM F-dex to GRLBD alone (blue) and wi
from two separate experiments (±SD).
(I) Average ligand KD for GRLBDwith and without chaperones determined from fiv
with chaperones (±SEM).
See also Figures S3 and S4.as with the D93N mutant of Hsp90 with p23, indicating that
accessing the closed state with p23 is an important aspect of
Hsp90’s chaperone function (Figure S7C). Together, this sug-
gests that Bag-1 acts within the pathway to promote nucleotide
exchange on Hsp70 in the stalled complex with Hsp90 and Hop.
Further evidence for this is seen when Bag-1 is added to the
GRLBD pull-down with the Hsp90 system. Addition of Bag-1
results in reduced levels of Hsp70 and Hop and significantly
enhances incorporation of p23 (Figure S3).
DISCUSSION
Under conditions where recombinant GRLBD is stable, recapit-
ulating the in vivo requirement for Hsp90 activation entailed
looking upstream in the pathway to the Hsp70 system. Here,
we showed that association with Hsp70 locally unfolds GRLBD
resulting in inactivation. From this inhibited state, Hsp90
promotes recovery of ligand binding, explaining the in vivo
requirement of Hsp90 for GR function. Instead of tenuous
interactions in a brief handoff, there is tight coordination of an
entire set of cochaperones with Hsp90, and this biochemical
coordination is matched by an integral physical coordination
seen in the cryo-EM reconstruction of the Hsp90:Hsp70:
Hop:GRLBD complex. In this complex, the interconnection be-
tween Hsp90 and Hsp70 manifests in the positioning of Hsp70
substrate binding region near the MD:CTD client binding site on
Hsp90 and the direct interaction between the two ATPase
domains. This provides a structural explanation for the coupling
of the two hydrolysis cycles observed by recovery in ligand
binding.
ATP hydrolysis by Hsp90 is essential for the reversal of the
Hsp70 inhibition. This is surprising given the expectation that
energy from hydrolysis is focused on driving client conforma-
tional rearrangements that promote activation. Instead, our re-
sults show that hydrolysis is utilized to regulate client transfer
and Hsp70 release. Our work also provides insight into how
Hsp90 inhibitors affect the chaperone system. Hsp90 inhibitors
that block the ATP binding pocket do not prevent the associa-
tion of Hsp90 to the intermediate complex with Hsp70, Hop,
and GR (Whitesell and Cook, 1996), but as shown here, they
block reversal of the Hsp70-mediated client inhibition. In vivo,one components (±SD). Assay conditions were 50 mM17AAG, 2 mMHsp40, and
sp40, and 15 mM Hsp70, Hop, and p23, with increasing Hsp90 WT (red), and
0 binding curve fit to a half-maximal effective concentration equation is shown.
with 2 mM Hsp40, and 15 mMHsp70, Hsp90, Hop, and p23 (red), fit to a single-
D (blue) and with 15 mM Hsp70, 2 mM Hsp40, and 10 mM Hsp90, Hop, and p23
EM) (Figure S4D).
ents for GRLBD (blue) and with 15 mMHsp70, 2 mMHsp40, and 10 mMHsp90,
be 0.165 ± 0.008 mM1min1 and 0.304 ± 0.072 mM1min1 with chaperones
th 15 mM Hsp70, 2 mM Hsp40, and 10 mM Hsp90, Hop, and p23 (red) averaged
e separate experiments (as in H). KD decreases from 201 ± 42 nM to 66 ± 12 nM
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Figure 5. Cryo-EM Reconstruction of Hsp90, Hsp70, Hop, and GRLBD Complex
(A) Cryo-EM reconstruction of Hsp90, Hsp70, Hop, and GRLBD complex.
(B) Cryo-EM reconstruction as in (A) with placement of Hsp70 NTD (3ATU) and SBD (1DKX) in cyan and Hsp90 NTD-rotated Hop model (Southworth and
Agard, 2011) in magenta. Client binding site residues for E. coli Hsp90 are E466, W467, and N470 shown in red andM546, M550, L553, and F554 in blue (Genest
et al., 2013).
(C) Top view shows density for the linker between Hsp70 domains (cyan).
(D) Top view showing positioning of Hsp70 NTD between Hsp90 NTDs.
See also Figures S5 and S6.inhibition of Hsp90’s ATPase results in the proteolytic degrada-
tion of GR, as well as other Hsp90 clients, revealing a direct
link between failure of client handoff and degradation that pro-
ceeds through Hsp70 pathways (Stankiewicz et al., 2010).
Hand off from Hsp70 to Hsp90 is thus a crucial regulation point
in which a client’s fate is determined.
In addition to the Hsp70 release function, comparison of
Hsp90 with the Hsp70 NEF, Bag-1, reveals that Hsp90 also
provides a chaperone function required for maintaining client
stability upon Hsp70 release. Our work provides direct evidence
of functional enhancements provided by the Hsp90 system1692 Cell 157, 1685–1697, June 19, 2014 ª2014 Elsevier Inc.and, moreover, explains the constitutive requirement for Hsp90
throughout the functional lifetime of GR and not just during initial
folding.
Hsp70 Binds to and Induces Partial Unfolding of GRLBD
Genetic studies have shown that deletion of Hsp40 in vivo leads
to elevated GR signaling in both the absence and presence of
hormone (Kimura et al., 1995). The Hsp40-dependent Hsp70
inhibition reported here explains this correlation. The elevated
GR signaling in the absence of hormone suggests a further role
of inactivation by Hsp70 beyond ligand binding inhibition and
Figure 6. Hydrolysis-Independent Chap-
erone Function of Hsp90 Is Important for
Maintaining an Active GR Population
(A) Experimental scheme for (B). GRLBD was
preinhibited by Hsp70 and Hsp40 and equilibrated
with F-dex. Ligand binding is initiated with either
Bag-1 or the Hsp90 system.
(B) Ligand binding initiated with Bag-1 (black),
Hsp90 with Hop and p23 (red), Hsp90(E47A) with
Hop and p23 (green), Bag-1 plus Hsp90 with Hop
and p23 (purple), and Bag-1 with Hsp90(E47A)
with Hop and p23 (yellow). Also shown is GRLBD
alone preincubated with F-dex (blue). Assay con-
ditions were 50 nM F-dex, 1 mM MBP-GRLBD,
2 mMHsp40, 15 mMHsp70, Hsp90, Hop, p23, and
Bag-1.
(C) Time course of light scattering as in (B) but
without F-dex for GRLBD (blue), and for GRLBD
preincubated with Hsp40 and Hsp70 as for (A),
with time course initiated with Bag-1 (black).
See also Figure S7.points to Hsp70 as a crucial component that holds GR in the
inactive, non-DNA binding state in the absence of ligand.
The observation that Hsp70 facilitates ligand release is sur-
prising. It implies that Hsp70 can bind to a ligand-bound form
of GRLBD and actively promote ligand dissociation, presumably
by unfolding. The minimal degree of unfolding observed in
GRLBD was also surprising because Hsp70 is known to bind
proteins in an unfolded state. In the crystal structure, Hsp70’s
lid latches down over the stretch of unfolded polypeptide, which
would require significant unfolding of the bound client (Zhu et al.,
1996). However, there is evidence that Hsp70 can bind to some
proteins while in more native states (Wawrzyno´w et al., 1995). Of
these, s32 was similarly shown to be only partially unfolded upon
Hsp70 binding (Rodriguez et al., 2008). In this case, recent evi-Cell 157, 1685–169dence revealed that the Hsp70 lid was
not in a fully locked down position
(Schlecht et al., 2011), suggesting that
Hsp70 could accommodate protein sub-
strates with varying degrees of tertiary
structure, such as a partially folded
GRLBD. In fact, the extended lid confor-
mation fits better into the EM density for
our complex than the bent conforma-
tion seen in the peptide-bound structure
(Figure S6C). Because most of the gain
in substrate affinity in the ADP state
comes from conformational changes
within the substrate binding site (Mayer
et al., 2000), it is plausible that GRLBD
is still securely bound.
More generally, Hsp70’s ability to
accelerate release of tightly bound GR
ligand suggests an unappreciated mech-
anism whereby catalyzed unfolding can
allow a more rapid response to sudden
decreases in cellular ligand concentra-tions. Chaperones have been proposed to be involved in disas-
sembly of transcription complexes (Freeman and Yamamoto,
2001); however, most of the attention has been centered around
Hsp90 and p23 (Freeman and Yamamoto, 2002). Our findings
suggest that the role of Hsp70 in promoting disassembly of GR
transcription complexes has been overlooked.
Modulation of GR’s Folded State by the Hsp70:Hsp90
System Results in Enhanced GR Stability, Function, and
Regulation
Although Hsp70’s role in GR delivery to Hsp90 had been studied
by Pratt and coworkers (reviewed in Pratt et al., 2006), the inac-
tivation function of Hsp70 and, therefore, the role of Hsp90 in
the reversal of the inhibition were not appreciated. This may be7, June 19, 2014 ª2014 Elsevier Inc. 1693
Figure 7. Model for GR Ligand Binding
Apo GRLBD on its own is mostly folded and
transiently samples a more unstructured state
where the binding pocket at the core of the pro-
tein is accessible, allowing ligand association and
dissociation. In a process that requires ATP hy-
drolysis and Hsp40, Hsp70 binds to GRLBD and
promotes ligand release by stabilizing a partially
unfolded inactive state. When GRLBD release
from Hsp70 is stimulated by the NEF Bag-1,
GRLBD is rapidly released in a partially unfolded
state that while able to bind ligand, is prone to
aggregation. In the presence of Hsp90, GRLBD-
bound Hsp70 is brought together with Hsp90 by
Hop, to form an inactive complex. Subsequent
ATP hydrolysis on Hsp90 is required to release
Hsp70 (and Hop), allowing progression to the
closed state, and p23 binding. Together, Hsp90
and Bag-1 cooperate to promote Hsp70 release
such that Hsp90 ATP hydrolysis is not required.
Progression to the matured complex with Hsp90
and p23 results in high-affinity ligand binding.because the GR used in these studies was in an inactive state
to begin with. It is worth noting that in related studies, purified
PR while on ice could bind ligand, and chaperones were only
required to maintain ligand binding under elevated temperatures
(Smith, 1993). Similarly, whereas our functional apo GRLBD
could be maintained at 25C, thermally induced aggregation of
GRLBD without the solubility-enhancing MBP tag was detected
at temperatures as low as 30C (data not shown). This indicates
that under our experimental conditions, the apo receptor was
only marginally stable. In addition, the full-length WT constructs
used by Pratt and coworkers were likely more unstable and were
likely misfolded or had already formed small aggregates such
that both Hsp70 and Hsp90 were required to cooperatively un-
fold and then refold the receptor in order to gain ligand binding.
This highlights the unstable nature of GR and the genuine need
for chaperone interactions in vivo.
Pratt and coworkers previously proposed that Hsp90 is
holding the ligand binding cleft open (Pratt et al., 2008). In their
model, Hsp70 is required to ‘‘prime’’ the receptor, whereas
Hsp90 opens the binding cleft in an ATP-dependent manner.
Our data show that the ‘‘priming’’ by Hsp70 is opening of the
binding pocket and that the crucial event resulting from ATP hy-
drolysis on Hsp90 is the release of Hsp70. In either case, the end
result is GRLBD bound to Hsp90 with an open binding pocket
(hence, our faster ligand on rate).
With this in mind, the nuclear hormone receptors likely evolved
a regulatory dependence on the Hsp90:Hsp70 chaperones
because they are a class of proteins where partial unfolding is
potentially beneficial. As represented in our model (Figure 7),1694 Cell 157, 1685–1697, June 19, 2014 ª2014 Elsevier Inc.we propose that the LBD has to partially
unfold to allow for ligand entry and
release. Unfolding by Hsp70 is thus
a crucial step in opening the bind-
ing pocket. The mechanism by which
Hsp70 achieves this is unclear. The coop-
erativity in the equilibrium inhibition couldbe the result of two Hsp70 binding events acting simultaneously;
however, with a multistate equilibrium of GRLBD conformations,
it could also be the result of different binding affinities between
one Hsp70 and the different GRLBD folded states, manifesting
as an apparent cooperativity. Kinetic modeling could not rule
out either model. Along these lines, a previous report suggested
that either one Hsp70 interactively cycles on GR or two Hsp70s
act sequentially in the Hsp70 priming step (Morishima et al.,
2001). Although the exact mechanism is still unknown, it is clear
that while bound to Hsp70, GRLBD lacks the essential structural
determinants for ligand binding, which can only be gained
once folding completes after Hsp70 release by either a NEF or
the Hsp90 system. Although GRLBD released in a partially
unfolded state by Bag-1 binds ligand more rapidly than GRLBD
alone, without the influence of Hsp90, it is prone to aggregation,
such that a fraction of the GRLBD population is lost during every
cycle of Hsp70 binding and release.
In the presence of the Hsp90 system, Hop recruits the
GRLBD:Hsp70 complex such that GRLBD is delivered in prox-
imity to Hsp90’s client binding site. The EM density suggests
that GRLBD ismaking direct contact with Hsp90while still bound
to Hsp70. From this inhibited state, Hsp70 release requires hy-
drolysis on Hsp90. Hop mediates this interaction by promoting
the NM rotation required to make contact between Hsp70 and
Hsp90 ATPase domains. In the absence of Hop, Hsp90 can likely
access this conformation, although with lower efficiency, thus
explaining the partial ligand binding recovery seen without
Hop. This is consistent with previous findings that also showed
50% GR activation without Hop (Morishima et al., 2000a) and
that Hop facilitated an Hsp70-Hsp90 interaction that can take
place without Hop, but with low efficiency (Morishima et al.,
2000b).
Although we do not provide direct evidence that Hsp90 pro-
motes ADP release from Hsp70, it is highly suggestive based
on the direct contacts between Hsp90 and Hsp70 in the EM
reconstruction. In the case of the catalytically dead Hsp90, this
complex is stalled, and GR activation cannot be achieved. How-
ever, ATP hydrolysis onHsp90 is not required for GR activation in
the presence of Bag-1. Our data suggest a model in which Bag-1
works within the Hsp90 pathway. Furthermore, in the EM struc-
ture, the Bag-1 (as well the bacterial exchange factor GrpE)
binding site on Hsp70 is accessible. This suggests that Hsp90
andNEFs canwork synergistically to promote nucleotide release
on Hsp70. This provides an explanation for GrpE’s ability to work
synergistically with bacterial Hsp90 and Hsp70 to refold dena-
tured proteins (Genest et al., 2011) and further suggests that
our findings extend to the Hsp70:Hsp90 system at a fundamental
level.
Together, this work illustrates how Hsp70 and Hsp90 function
as the yin and yang of protein folding in the cell. Although the un-
folding/inactivation by Hsp70 and the refolding/reactivation by
Hsp90 might seem wastefully contradictory, their combination
can be complementary. Constant rounds of Hsp70-mediated
unfolding/ligand release and Hsp90-mediated refolding/ligand
binding facilitate GR’s ability to provide both rapid and subtle
responses to changing hormone levels while also maintaining
apo GR in a nonaggregating, high-affinity state. Moreover this
provides opportunities for regulatory control and to coordinate
signaling with protein homeostasis. Additionally, the reliance of
both chaperones on cochaperones and numerous posttransla-
tional modifications enables additional levels of fine-tuning.
Repeated cycles of unfolding and refolding have the additional
benefit of allowing the chaperones to ensure a functional prote-
ome by preventing the buildup of nonfunctional misfolded states
and utilizing refoldability as a metric for targeting damaged pro-
teins for degradation. These results provide clear benefits and
reasons beyond stability for why many signaling proteins have
evolved a dependence on the Hsp70:Hsp90 chaperone system.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Human Hsp90a, Hsp70, Hop, and p23 and yeast YDJ1 were expressed in the
pET151 bacterial expression plasmid with a cleavable 63 His tag and purified
as previously described (Southworth and Agard, 2011). Human Bag-1 was ex-
pressed in a pET28a vector with a cleavable 63 His tag and purified as above.
For cryo-EM, Hsp70 was purified from Sf9 cells as previously described
(Southworth and Agard, 2011). For GRLBD, the LBD(F602S) (521–777) was
cloned into a pMAL-c2X derivative with an N-terminal cleavable 63 His-MBP
tag and a pACYCDuet derivative with a cleavable 63 His tag. Briefly, GRLBD
was expressed in BL21 star (DE3) at 16C in the presence of dex and purified
by Ni-affinity chromatography and ion exchange in the presence of ligand.
Ligand was then removed by overnight dialysis and excluded from size-exclu-
sion chromatography (SEC). Purification was finished by extensive dialysis into
ligand-free buffer. See Extended Experimental Procedures for details.
Fluorescence Polarization Assays
Fluorescence polarization of F-dex (Life Technologies) was measured on
a SpectraMax M5 plate reader (Molecular Devices) with excitation/emissionwavelengths of 485/538 nm, temperature control set at 25C, and in 30 mM
HEPES (pH 7.5), 150 mM KCl, and 2 mM DTT. See Extended Experimental
Procedures for details.
HDX-MS
Solution-phase amide HDX was carried out with a fully automated system
(Goswami et al., 2013). GRLBD and Hsp70 were mixed at 1:1.2 molar ratio
with 2 mMHsp40 and 5mMATP/MgCl2 and incubated for 1 hr at room temper-
ature before HDX. For HDX, 5 ml of 10 mMGRLBD or the complex (GRLBD and
Hsp70) was diluted to 25 ml with deuterium oxide-containing HDX buffer and
incubated at 4C for 10, 30, 60, 300, 900, or 3,600 s. Following exchange,
the protein was denatured by dilution to 50 ml with 0.1% (v/v) trifluoroacetic
acid in 3 M urea and 50 mM tris-(2-carboxyethyl)phosphine (TCEP) and sub-
jected to online pepsin digestion and electrospray ionization directly coupled
to a high-resolution (60,000 at m/z 400) Orbitrap mass spectrometer (LTQ
Orbitrap XL with ETD; Thermo Fisher Scientific). In-house software was used
for analysis (Pascal et al., 2012). For back-exchange correction, an average
of 70% recovery was estimated.
Aggregation Assay
Aggregation was monitored with a Jobin Yvon FluoroMax-3 fluorescence
spectrophotomer with a temperature-controlled jacket set to 25C. Right-
angle light scattering was measured with excitation and emission wavelengths
set to 500 nm with 1.4 nm slit widths.
Assembly of Hsp90-Hsp70-GR Loading Complex
Hsp90, Hop, Hsp70, MBP-GRLBD, and Hsp40 were incubated with ATP for
1 hr at room temperature. The complex was purified by SEC with an Ettan
LC (GE Healthcare). Fractions were crosslinked with 0.02% glutaraldehyde
for 20 min at room temperature and quenched with 20 mM Tris HCl (pH 7.5).
Crosslinked fractions were analyzed by SDS-PAGE. Fractions containing the
full complex were used for cryo-EM data collections. See Figure S5 for details.
EM and 3D Reconstructions
Cryo-EM data were collected as previously described (Southworth and Agard,
2011). A total of 10,149 particles were picked from 214 images with a 2.2–4 mm
defocus range. Defocus values were determined using CTFFIND (Mindell and
Grigorieff, 2003) and corrected using a Weiner filter. An initial model was built
from a featureless sphere with 2D class averages by projection matching
in SPIDER (Frank et al., 1996). The 3D reconstruction was preformed using
EMAN with ten rounds of refinement with 15 angular increments (Ludtke
et al., 1999). The resolution was determined by the even-odd test in EMAN.
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The cryo-EM reconstruction has been deposited in the EMDataBank under the
ID code EMD-5981.
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